IL109749A - Rectal Pharmaceutical Preparations Containing 1, 2, 3, 9 - Tetrahydro - 9 - Methyl -3 -]) 2 - Methyl - H1 - Imidazole - 1 - Il (- Methyl - - Google Patents

Rectal Pharmaceutical Preparations Containing 1, 2, 3, 9 - Tetrahydro - 9 - Methyl -3 -]) 2 - Methyl - H1 - Imidazole - 1 - Il (- Methyl -

Info

Publication number
IL109749A
IL109749A IL10974994A IL10974994A IL109749A IL 109749 A IL109749 A IL 109749A IL 10974994 A IL10974994 A IL 10974994A IL 10974994 A IL10974994 A IL 10974994A IL 109749 A IL109749 A IL 109749A
Authority
IL
Israel
Prior art keywords
methyl
pharmaceutical composition
active ingredient
imidazol
tetrahydro
Prior art date
Application number
IL10974994A
Other languages
English (en)
Hebrew (he)
Other versions
IL109749A0 (en
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of IL109749A0 publication Critical patent/IL109749A0/xx
Publication of IL109749A publication Critical patent/IL109749A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL10974994A 1993-05-25 1994-05-24 Rectal Pharmaceutical Preparations Containing 1, 2, 3, 9 - Tetrahydro - 9 - Methyl -3 -]) 2 - Methyl - H1 - Imidazole - 1 - Il (- Methyl - IL109749A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310756A GB9310756D0 (en) 1993-05-25 1993-05-25 Compositions

Publications (2)

Publication Number Publication Date
IL109749A0 IL109749A0 (en) 1994-08-26
IL109749A true IL109749A (en) 1999-03-12

Family

ID=10736089

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10974994A IL109749A (en) 1993-05-25 1994-05-24 Rectal Pharmaceutical Preparations Containing 1, 2, 3, 9 - Tetrahydro - 9 - Methyl -3 -]) 2 - Methyl - H1 - Imidazole - 1 - Il (- Methyl -

Country Status (38)

Country Link
US (1) US5741806A (xx)
EP (1) EP0700290B1 (xx)
JP (1) JP2965703B2 (xx)
KR (1) KR100297212B1 (xx)
CN (1) CN1106194C (xx)
AP (1) AP544A (xx)
AT (1) ATE183643T1 (xx)
AU (1) AU680918B2 (xx)
BE (1) BE1007158A3 (xx)
BR (1) BR1100046A (xx)
CA (1) CA2162919C (xx)
CO (1) CO4230094A1 (xx)
CY (1) CY2411B1 (xx)
CZ (1) CZ291041B6 (xx)
DE (1) DE69420266T2 (xx)
DK (1) DK0700290T3 (xx)
EC (1) ECSP941088A (xx)
ES (1) ES2136198T3 (xx)
FR (1) FR2705569B1 (xx)
GB (2) GB9310756D0 (xx)
GR (1) GR3031669T3 (xx)
HR (2) HRP940315B1 (xx)
HU (1) HU227121B1 (xx)
IE (1) IE80632B1 (xx)
IL (1) IL109749A (xx)
IS (1) IS1868B (xx)
IT (1) IT1272990B (xx)
MY (1) MY111445A (xx)
NO (1) NO306448B1 (xx)
NZ (1) NZ267415A (xx)
PE (1) PE13395A1 (xx)
PL (1) PL175578B1 (xx)
RU (1) RU2132684C1 (xx)
SA (1) SA94150003B1 (xx)
SG (1) SG48119A1 (xx)
SI (1) SI0700290T1 (xx)
WO (1) WO1994027599A1 (xx)
ZA (1) ZA943593B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
CZ20004736A3 (cs) * 1998-06-15 2001-09-12 Sepracor, Inc. Farmaceutický prostředek
IL140118A0 (en) 1998-06-15 2002-02-10 Sepracor Inc Use of optically pure (+) norcisapride for treating apnea, bulimia and other disorders
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
CA2774959C (en) * 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57809B1 (en) * 1984-01-25 1993-04-21 Glaxo Group Ltd 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8627909D0 (en) * 1986-11-21 1986-12-31 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy

Also Published As

Publication number Publication date
HU9503375D0 (en) 1996-01-29
IL109749A0 (en) 1994-08-26
GR3031669T3 (en) 2000-02-29
GB2279008A (en) 1994-12-21
SG48119A1 (en) 1998-04-17
SA94150003B1 (ar) 2005-04-11
ES2136198T3 (es) 1999-11-16
CZ291041B6 (cs) 2002-12-11
JP2965703B2 (ja) 1999-10-18
ITRM940322A1 (it) 1995-11-24
HRP940315B1 (en) 2000-12-31
ZA943593B (en) 1995-02-13
AP544A (en) 1996-10-11
RU2132684C1 (ru) 1999-07-10
PL175578B1 (pl) 1999-01-29
PE13395A1 (es) 1995-05-25
GB9310756D0 (en) 1993-07-14
PL311721A1 (en) 1996-03-04
AU680918B2 (en) 1997-08-14
FR2705569B1 (fr) 1995-11-10
US5741806A (en) 1998-04-21
GB2279008B (en) 1997-06-18
HU227121B1 (en) 2010-07-28
AP9400643A0 (en) 1994-07-31
NO306448B1 (no) 1999-11-08
SI0700290T1 (en) 1999-12-31
IS1868B (is) 2003-05-02
KR100297212B1 (ko) 2001-10-24
ITRM940322A0 (it) 1994-05-24
ECSP941088A (es) 1994-11-16
DE69420266T2 (de) 1999-12-09
CN1124454A (zh) 1996-06-12
HRP940315A2 (en) 1996-08-31
HUT74867A (en) 1997-02-28
GB9409835D0 (en) 1994-07-06
DE69420266D1 (de) 1999-09-30
HRP970315A2 (en) 1999-04-30
WO1994027599A1 (en) 1994-12-08
CN1106194C (zh) 2003-04-23
EP0700290A1 (en) 1996-03-13
IT1272990B (it) 1997-07-01
CY2411B1 (en) 2004-11-12
NO954783L (no) 1995-11-24
AU6970994A (en) 1994-12-20
JPH08510457A (ja) 1996-11-05
CA2162919C (en) 1999-07-20
IE940420A1 (en) 1994-11-30
IE80632B1 (en) 1998-10-21
IS4168A (is) 1994-11-26
EP0700290B1 (en) 1999-08-25
FR2705569A1 (fr) 1994-12-02
DK0700290T3 (da) 2000-03-13
CA2162919A1 (en) 1994-12-08
CZ308595A3 (en) 1996-06-12
NO954783D0 (no) 1995-11-24
MY111445A (en) 2000-05-31
BE1007158A3 (fr) 1995-04-11
ATE183643T1 (de) 1999-09-15
CO4230094A1 (es) 1995-10-19
NZ267415A (en) 1997-10-24
BR1100046A (pt) 1999-11-23

Similar Documents

Publication Publication Date Title
GB2200046A (en) Pharmaceutical compositions for gastric disorders
AP544A (en) Compositions for rectal administration
US5705506A (en) Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration
AU626010B2 (en) Medicaments
EP0345931A1 (en) Certain PAF antagonist/antihistamine combinations and methods
JPH01316319A (ja) 医薬
EP0567498A1 (en) Pharmaceutical composition containing granisetron and dexamethasone
JPH01250319A (ja) 医薬

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired